Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Issue 1 (14th March 2019) - Amin, Asim; Plimack, Elizabeth R.; Ernstoff, Marc S.; Lewis, Lionel D.; Bauer, Todd M.; McDermott, David F.; Carducci, Michael; Kollmannsberger, Christian; Rini, Brian I.; Heng, Daniel Y. C.; Knox, Jennifer; Voss, Martin H.; et al.